March 9, 2017
BMS appoints lung cancer specialist as EVP and CSO
Bristol-Myers Squibb has appointed Dr. Thomas J. Lynch, Jr. executive vice president and chief scientific officer, effective March 16, 2017.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Dr. Thomas J. Lynch